Efficacy, safety, and tolerability of fulranumab, an anti-nerve growth factor antibody, in treatment of patients with moderate-to-severe osteoarthritis pain

Authors
Category Primary study
JournalJournal of Pain
Year 2011
This article has no abstract
Epistemonikos ID: 6cf289bcfbd47c51367ccec1950fc328a4dbc43e
First added on: Feb 04, 2025